Press Room

WASHINGTON, D.C.

California Governor Gavin Newsom announced he has signed Senate Bill 496, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence.

Earlier this week, 22 cancer patient and caregiver advocacy groups, including the American Cancer Society Cancer Action Network (ACS CAN), sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations on how the agency should consider pharmaceutical therapeutic alternatives to selected oncology drugs for 2026 Medicare plans as they head into the negotiation process laid out in the Inflation Reduction Act (IRA). 

The American Cancer Society Cancer Action Network (ACS CAN) was thrilled to see the Senate Health Policy Committee pass oral chemotherapy fairness legislation unanimously today. 

FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild.

Fargo native Ben Hanson has joined the American Cancer Society Cancer Action Network (ACS CAN) as the government relations director for North Dakota and South Dakota.

MINNEAPOLIS, Minn. — This September, communities will honor lives affected by cancer when Lights of Hope Across America takes place on the front porches, kitchen tables and lawns of cancer patients, survivors and advocates nationwide and in Washington, D.C.

RALEIGH, N.C. –  The North Carolina legislature passed the fiscal year 2023 biennium budget today that included $1 billion in additional funds for Medicaid expansion, allocated annually. The passage came after weeks of negotiations that have delayed implementation of Medicaid expansion.

ACS CAN and leading public health, consumer and provider groups filed an amicus curiae (or friend-of-the-court) brief in the case of Loper Bright Enterprises v. Raimondo urging the Supreme Court of the United States (SCOTUS) not to overturn the “Chervon deference." This would pose a significant threat to the country’s health care system by undermining the work of federal health agencies such as the Centers for Medicare and Medicaid Services (CMS).  

Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on draft guidance related to the maximum monthly cap on patient co-payments under prescription drug plans, referred to as the Medicare Prescription Payment Plan, which will begin in plan year 2025.